ANNECY, France, June 30, 2011 /PRNewswire/ --
Over 70 international experts in medicine, infectious diseases,
microbiology and epidemiology, from every continent, gathered at
the Fondation Mérieux's Conference Center for the third edition of
the World HAI Forum on healthcare-associated infections, a
bioMérieux initiative. Forum participants call upon national and
international health authorities and policy makers, the medical and
veterinary communities, Industry, and the general public to take
action to avoid an impending public health catastrophe caused by
the emergence and spread of bacteria that are resistant to all
While research to discover novel antibiotics has slowed to a
virtual standstill, bacterial resistance has increased due to the
massive use and misuse of antibiotics, not only for human health,
but also for animals. The treatment of certain common infections is
becoming difficult and the success of immunosuppressive therapies
and surgical interventions (organ transplants, cardiac surgery),
which are associated with a high risk of bacterial infection, could
To the Forum experts, the emergence of pan-resistant NDM-1
bacteria and epidemic of multidrug-resistant
E. coli infections currently in Europe should be
taken as a major public health warning, indicating that a new era
of antimicrobial resistance has begun. This must lead to a global
awakening: the protection of antibiotics has now entered the sphere
of sustainable development.
In a continuation of calls to action and proposals made by major
national and international organizations (WHO, ECDC, IDSA, CDC,
etc.), the Forum's participants identified priority action areas to
fight bacterial resistance and recommended 12 very concrete actions
to be implemented, in the short to mid-term, to effectively address
this serious problem.
for policy makers and health authorities
- For animals, stop the administration of antibiotics used in
human medicine and limit antibiotics to therapeutic use only. It is
imperative to reserve the most important classes of antibiotics for
- Banish, in all countries, the use of antibiotics as growth
promoters in animal feed.
- Regulate the sale of antibiotics for use in human medicine and
prohibit over-the-counter sales worldwide.
- Have international organizations (WHO, European Union) develop
a charter on good antibiotic stewardship and have all the
ministries of health worldwide sign it and commit to respecting
for the human and veterinary healthcare communities
- Establish standardized, universal surveillance of antibiotic
use and resistance and monitor the emergence and spread of new
forms of bacterial resistance.
- Include, in the medical and veterinary school curricula, a
solid training in bacterial resistance and the prudent use of
antibiotics and establish on-the-job training programs for
healthcare workers, taking into account the cultural specificities
of each country.
for the general public
- Develop culturally sensitive awareness campaigns, targeted to
the general public, explaining the importance of protecting
antibiotics and using them only when absolutely necessary.
- Provide education about fundamental hygiene, such as
handwashing to prevent the spread of infection. It is imperative to
improve sanitation systems to eliminate resistant bacteria in
- Include consumers in the development and implementation of
- Develop Point-of-Care and rapid diagnostic tests, which can be
used at the patient's bedside or the doctor's office, to guide the
prescription of antibiotics and avoid their prescription for viral
- Stimulate research and development of novel antibiotics.
- Find new economic models, which reconcile public health
interests with Industry needs for profitability.
About the World HAI Forum
To hear what experts discussed at the Forum: http://www.hai-forum.com
For more information visit:http://www.bioMerieux.com/hai-resistance
Organized from June 27-29, the 3rd edition of the World HAI
Forum was characterized by the exceptional geographical diversity
of its participants, coming from 33 countries.
While most meetings focus on scientific developments
retrospectively in an academic format, the World HAI Forum, which
is held every two years, gives participating experts a chance to do
prospective analysis of subjects that are not usually discussed.
More time is devoted to sharing best practices, successes and
failures in the fight against multidrug-resistant bacteria, as a
basis for building effective action plans.
A world leader in microbiology and a pioneer in resistance
detection and susceptibility testing, bioMérieux works closely with
healthcare professionals in the three key areas of Infection
Control: Prevention, Surveillance and Intervention. Diagnostic
tests are paramount to success in the fight against infections with
As part of its commitment to fight HAIs and microbial
resistance, bioMérieux has also held HAI symposia around the world
over the past 3 years, in countries including the United States,
Belgium, the Netherlands, Portugal, Spain, China, Japan, Korea,
Colombia and Saudi Arabia.
Diagnostics to Improve Public Health
A world leader in the field of in vitro diagnostics for
over 45 years, bioMérieux is present in more than150 countries
through 39 subsidiaries and a large network of distributors. In
2010, revenues reached 1.357 billion with 87% of sales outside of
bioMérieux provides diagnostic solutions (reagents, instruments,
software) which determine the source of disease and contamination
to improve patient health and ensure consumer safety. Its products
are used for diagnosing infectious diseases and providing high
medical value results for cancer screening and monitoring and
cardiovascular emergencies. They are also used for detecting
microorganisms in agri-food, pharmaceutical and cosmetic
bioMérieux is listed on the NYSE Euronext Paris market (Symbol:
BIM - ISIN: FR0010096479). Other information can be found at
Tel: + 33-4-78-87-20-08
Tel: + 1-910-509-3976